[Federal Register: December 2, 2003 (Volume 68, Number 231)]
[Notices]
[Page 67478]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr02de03-103]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated June 25, 2003, and published in the Federal
Register on July 14, 2003, (68 FR 41663), Novus Fine Chemicals, LLC,
611 Broad Street, Carlstadt, New Jersey 07072, made application by
renewal to the Drug Enforcement Administration for registration as a
bulk manufacturer of the basic class of Methylphenidate (1724), a
Schedule II controlled substance.
The firm plans to manufacture bulk Methylphenidate to distribute to
its customers for the manufacture of finished products.
No comments or objections have been received. DEA has considered
the factors in title 21, United States Code, section 823(a) and
determined that the registration of Novus Fine Chemicals, LLC, to
manufacture the listed controlled substance is consistent with the
public interest at this time. DEA has investigated Novus Fine
Chemicals, LLC, to ensure that the company's registration is consistent
with the public interest. This investigation has included inspection
and testing of the company's physical security systems, verification of
the company's compliance with state and local laws, and a review of the
company's background and history. Therefore, pursuant to 21 U.S.C. 823
and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office
of Diversion Control, hereby orders that the application submitted by
the above firm for registration as a bulk manufacturer of the basic
class of controlled substance listed is granted.
Dated: November 19, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 03-29973 Filed 12-1-03; 8:45 am]
BILLING CODE 4410-09-M